Adenotonsillar enlargement in pediatric patients following solid organ transplantation

Archives of Otolaryngology - Head and Neck Surgery

Volumn 126, Issue 2, 2000, Pages 159-164

  Huang, Robert Y ^b   Shapiro, Nina L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOIDECTOMY; ADENOTONSILLECTOMY; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PALATINE TONSILLITIS; TONSIL DISEASE; TREATMENT INDICATION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT OBSTRUCTION;

EID: 0033954521     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.126.2.159     Document Type: Article

References (16)

1. Basgoz N, Preiksaitis JK. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am. 1995;9:901-923.
2. Sokal EM, Antunes H, Beguin C, et al. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation. 1997;64:1438-1442.
3. Green M, Cacciarelli TV, Mazariegos GV, et al. Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation. 1998; 66:1641-1644.
4. Myer CM, Reilly JS. Airway obstruction in an immunosuppressed child. Arch Otolaryngol Head Neck Surg. 1985;111:409-411.
5. Lones MA, Mishalani S, Shintaku IP, Weiss LM, Nichols WS, Said JW. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. Hum Pathol. 1995;26:525-530.
6. Yellin SA, Weiss MH, Kraus DH, Papadopoulos EB. Tonsil lymphoma presenting astonsillitis after bone marrow transplantation. Otolaryngol Head Heck Surg. 1995; 112:544-548.
7. Kraus MD, Crawford DF, Kaleem Z, Shenoy S, MacArthur CA, Longtine JA. Tg/b hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder. Cancer. 1998;82:983-992.
8. Ho M. Risk factors and pathogenesis of posttransplant lymphoproliferative disorders. Transplant Proc. 1995;27(suppl 1):38-40
9. Cacciarelli TV, Green M, Jaffe R, et al. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus therapy. Transplantation. 1998;66:1047-1052.
10. Dror Y, Greeenberg M, Taylor G, et al. Lymphoproliferative disorders after organ transplantation in children. Transplantation. 1999;67:990-998.
11. Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol. 1997;14:8-14.
12. Potsic WP. Assessment and treatment of adenotonsillar hypertrophy in children. Am J Otolaryngol. 1992;13:259-264.
13. Fairley JW, Hunt BJ, Glover GW, Radley-Smith RC, Yacoub MH. Unusual lymphoproliferative oropharyngeal lesions in heart and heart-lung transplant recipients. J Laryngol Otol. 1990;104:720-724.
14. Grundfast KM, Wittich DJ, Adenotonsillar hypertrophy and upper airway obstruction in evolutionary perspective. Laryngosocope. 1982;92:650-656.
15. Kearns DB, Pransky SM, Seid AB. Current concepts in pediatric adenotonsillar disease. Ear Nose Throat J. 1991;72:15-19.
16. Deutsch ES. Tonsillectomy and adenoidectomy: changing indications. Pediatr Clin North Am. 1996;43:1319-1338.